BRTX
BioRestorative Therapies Inc
NASDAQ: BRTX · HEALTHCARE · BIOTECHNOLOGY
$0.23
+11.60% today
Updated 2026-04-30
Market cap
$5.86M
P/E ratio
—
P/S ratio
16.28x
EPS (TTM)
$-1.58
Dividend yield
—
52W range
$0 – $2
Volume
10.4M
BioRestorative Therapies Inc (BRTX) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-19,517.00%
ROE
-320.50%
ROA
-119.60%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2009 | — | — | — | — | — |
| 2010 | — | $-2.26M | — | — | — |
| 2011 | — | $-4.07M | — | — | — |
| 2012 | $15589.00 | $-6.54M | 91.62% | -35,746.05% | -41,931.63% |
| 2013 | $1680.00 | $-5.75M | 87.62% | -282,873.21% | -342,332.98% |
| 2014 | $415996.00 | $-5.59M | 48.60% | -1,183.31% | -1,343.19% |
| 2015 | $628915.00 | $-7.92M | 58.42% | -1,140.12% | -1,259.87% |
| 2016 | $36355.00 | $-8.64M | 99.72% | -21,447.55% | -23,755.44% |
| 2017 | $81000.00 | $-9.44M | -220.07% | -10,338.62% | -11,660.07% |
| 2018 | $111000.00 | $-12.52M | 100.00% | -6,889.78% | -11,277.30% |
| 2019 | $130000.00 | $-14.65M | — | -6,486.16% | -11,267.61% |
| 2020 | $77000.00 | $-11.27M | 100.00% | -3,574.12% | -14,639.85% |
| 2021 | $46000.00 | $-44.30M | 100.00% | -57,191.03% | -96,311.51% |
| 2022 | $119800.00 | $-13.22M | 100.00% | -15,838.08% | -11,036.97% |
| 2023 | $145800.00 | $-10.42M | 100.00% | -10,439.49% | -7,145.20% |
| 2024 | $401000.00 | $-8.98M | 93.00% | -2,881.59% | -2,239.25% |
| 2025 | $359700.00 | $-14.24M | 93.37% | -4,350.05% | -3,959.40% |